🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Sjögren's Foundation Steven Zhao A recent study by Vasco C Romao et al. investigates predictors of worsening systemic involvement in patients with Sjögren’s disease. 👉 Younger age at diagnosis and positive biopsy and rheumatoid factor are predictors of systemic disease. 👉 bit.ly/3YfTA4q

Minions nos Jogos Olímpicos! Que vídeo lindo ❤ x.com/SEvideos_/stat…

Cuando te despierta un mosquito de madrugada #CeremoniaDeApertura #Paris2024 #SalutParisRTVE

Quatro em quatro anos vemos a pobreza que somos enquanto nação de desporto. Levanta zero reflexões. Circo do futebol allez

Rather than stopping the GLP-1, use a low maintenance dose otherwise the patient regains weight quickly #ACR24 @rheumnow

FDA has given FDA Breakthrough Therapy designation to Nipocalimab for treatment of adults w/ moderate-to-severe Sjögren’s disease. NIPO is an Ab to neonatal Fc receptor (FcRn), & was tested and shown effective in Sjog in the Phase 2 DAHLIAS study - a plenary presentation at

Amazing talk by Christoph Thaiss at #ACR24 on the role of stress on inflammation! One of the highlights for me so far. Small room though, more attention needed to this important topic we see every day in clinic. Stress —> inflammatory response—>IMIDs, flares, poor outcomes 🔥

Do you remember when you joined -X- Twitter? I do! #MytwitterAnniversary

Happy to present at #ACR24 our first data on scRNAseq and spatial transcriptomics in #Sjogrens. Minor salivary glands of early and late SjD revealed many different types of cell populations. More to come! Joint effort Luis Graca lab iMM with #rheum & #path ULS Santa Maria

Interesting thought provoking study from UAE. 28% HCPs (physicians or nurses) had fibromyalgia! Most w/ moderate or severe stress levels. More than half thought about quitting. No stress reduction activities due to “no time”. Work stress->fatigue. This is not sustainable. #ACR24

Cool sessions at #ACR24

Loiseau et al. 4700 pSS, 47000 comparators. pSS associated with increased risk of every CV/VTE outcome. Did not have that in my priors! Dr. John Cush #ACR24 Abstr#2631 acrabstracts.org/abstract/risk-…

Loiseau #2631 increased risk of MI, (HF), stroke, VTE and peripheral artery disease in Danish patients with #Sjogrens disease, compared to general population. Some variation according to time since diagnosis. No adjustment for smoking though. Important epidemiological data #ACR24

I knew it!

Apparently, oil-pulling reduces gingival infections and promotes oral health in people living with Sjogren disease! #ACR24

Conaghan et al. LEVI-04, neurotrophin-3 inhibitor in knee OA. 518 patients. Significant improvements in WOMAC pain and function, and PGA. So sign of any increase in rapidly progressive OA (as with NGF inhibitors) Dr. John Cush #ACR24 Abstr#L15 acrabstracts.org/abstract/levi-…

Live from #ACR24: Promising results from PHOENYCS GO trial! DZP, a CD40L inhibitor, showed a 49.5% BICLA response at Week 48 (vs 34.6% with PBO+SOC). Hierarchical significance not achieved. Steroid tapering to ≤7.5 mg/day achieved in 72.4% of patients. André Ribeiro

Exercise should not be an option or alternative but the cornerstone of rheumatic diseases treatment

Promotion of #PhysicalActivity is essential at all stages of adult life ✅Consistently associated with lower risk of mortality across all ages ✅Greater reduction in risk in older ages especially at high levels of physical activity 👉🏽jamanetwork.com/journals/jaman… via JAMA Network Open